Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2877177 Title: DERIVES DE TYPE AZAINDAZOLE OU DIAZAINDAZOLE POUR LE TRAITEMENT DE LA DOULEUR

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
137458139
WO application number:
EP2013065907
Type:
European patent granted for BE
Status:
Open
Publication number:
2877177
WO publication number:
WO2014016433
1rst applicant's nationality:
Translation language:
French
EPO publication language:
English
SPC number:

Dates

Filing date:
29/07/2013
Grant date:
26/10/2016
EP publication date:
03/06/2015
WO publication date:
30/01/2014
Claims translation received date:
Translation received date (EP publication B1):
25/01/2017
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
26/10/2016
EP B1 publication date:
26/10/2016
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
29/07/2033

Applicant

Name:
Pierre Fabre Médicament
Legal Form:
From:
26/10/2016
Address:
45, Place Abel Gance, 92100 Boulogne-Billancourt, France (FR)
To:

Agent

Name:
TEXIER Christian
Legal Form:
From:
25/01/2017
Address:
Rue de Chazelles 20, 75847, PARIS CEDEX 17, France (FR)
To:

Inventor

1

Name:
SOKOLOFF, Pierre
Legal Form:
Address:
F-81540 Belleserre, France (FR)

2

Name:
CACHOUX, Frédéric
Legal Form:
Address:
F-31460 Caraman, France (FR)

Priority

Priority patent number:
12305922
Priority date:
27/07/2012
Priority country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
A61K 31/437; A61K 31/4985; A61K 31/5025; A61K 31/519; A61P 29/00;

Publication

Bulletin

Bulletin heading:
EP3
Journal edition number:
2017/01b
Publication date:
16/09/2019
Description:
Contains data concerning European patents granted for Belgium and published (B1 publication) in English and for which a translation in Dutch, French or German was filed under the Belgian Patent Laws

European Patent Bulletin

Issue number:
201643
Publication date:
26/10/2016
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
31/07/2025
Annual fee number:
13
Annual fee amount:
275 Euro
Expected payer:
Last annual fee payment date:
26/07/2024
Last annual fee paid number:
12
Last annual fee paid amount:
240 Euro
Payer:
ACUMASS
Filing date Document type Publication Type Document Description Number of pages File Type
27/01/2017 Translations 223 PDF /4/9/7/5/5/0721555794/docs/137458139_0_translations_20170206_035606113.pdf